AAFP launches consumer site

Share this article:
AAFP launches consumer site
AAFP launches consumer site
Why should WebMD and EverydayHealth have all the fun? The American Academy of Family Physicians is launching a video-centric consumer site offering peer-reviewed health information in a high-definition, video-on-demand format.

AAFP is partnering with Chicago-based broadcast and interactive production shop AnswersMedia on the ad-supported site, at familydoctor.org, in a venture dubbed Primetime HealthNet. The site features English- and Spanish-language content on top health topics and prevalent conditions like diabetes, heart disease, HIV and allergies. Content will be reviewed by medical editors who are family physicians.

AAFP and AnswersMedia plan to add “HIPAA compliant online physician tools that will allow for education-driven communications with patients.” For advertisers, the site's offering includes multiple targeted placement positions and will ultimately include “assigned trigger points that lead visitors to bonus content, including promotional content and targeted e-commerce opportunities.”

Familydoctor.org already attracts more than 3 million unique users and 5.6 million page views a month, the medical association said, and AAFP is in talks with "a number of prospective distribution channels" including other medical societies, hospitals and pharmacies about syndicating content from the site.

"We think this is going to be a game changer," said Michael Springer, AAFP's VP, publishing and communications.“We are witnessing a true media and technology convergence and believe that by putting a trusted physician at the core of information flow, we can increase viewership and visibility for familydoctor.org and create a new venue for advertising, sponsorship and licensing of trusted, in-demand, on-demand health content.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...